<DOC>
	<DOCNO>NCT00891423</DOCNO>
	<brief_summary>Meropenem powerful antibiotic use intensive care people serious infection . Meropenem rapidly remove blood kidney expensive . In ill patient intensive care , uncertain best give antibiotic . Studies suggest small dose give longer period time , result blood level meropenem good high dose give short period time . This direct comparison test intensive care patient . It important know give less amount slowly good , doctor choose give meropenem way . To establish whether case , investigator plan conduct initial ( pilot ) study ten intensive care patient Austin hospital . Adult ( age 18 year old ) patient intensive care serious infection treat antibiotic , meropenem three day able participate study . The decision start meropenem make intensive care doctor give usual way 24 hour . The investigator random way ( like toss coin ) , give participant meropenem either usual way ( 1 gram infuse 30 minute ) give small amount , long period time ( 500 milligram infuse 3 hour ) . This do 24 hour . They receive meropenem alternative way another 24 hour . After time intensive care doctor decide meropenem continue give . Blood level meropenem measure see meropenem give two different way . During different way give meropenem , 7 blood sample need take . Ten ml ( one spoonful ) blood require measurement . Blood level take monitoring line , already present . Other information also collect participant study . This include age , gender , height , weight , information medical condition measurement well kidney function .</brief_summary>
	<brief_title>A Study Meropenem Standard 30 Minute Infusion Versus Prolonged 3 Hour Infusion Intensive Care Unit ( ICU ) Patients</brief_title>
	<detailed_description>The use pharmacodynamic pharmacokinetic principle antibiotic dosing advocate enable effective efficient use antibiotic . The current standard care Austin ICU give meropenem 1g via short ( 30 min ) infusion . Small study healthy volunteer intensive care patient Monte Carlo simulation model group , show prolonged infusion meropenem provide least equivalent T &gt; MIC use small dose . Studies intensive care patient generally exclude renal failure , septic shock certain co-morbidities . Therefore , study encompass group patient receive meropenem intensive care set require show finding generalise applicability . Hypothesis/research question : 500mg meropenem administer 3 hour infusion least comparable traditional dose 1 g administer 30 minute infusion , attain target time MIC . We plan compare standard meropenem therapy ( 1g 30 minute infusion ) prolong infusion meropenem ( 500mg 3 hour infusion ) general intensive care unit . Meropenem level monitor high performance liquid chromatography ( HPLC ) analysis ( Victorian College Pharmacy ) determine pharmacokinetic pharmacodynamic outcome different dose regimen correlate meropenem MIC significant bacterial isolates patient The outcome pilot study help plan large project improve use meropenem intensive care unit patient .</detailed_description>
	<mesh_term>Meropenem</mesh_term>
	<mesh_term>Thienamycins</mesh_term>
	<criteria>Adult intensive care patient Predicted duration treatment 3 day Predicted duration treatment le 3 day Hypersensitivity meropenem betalactams Consent unable obtain participant next kin Suspected proven bacterial meningitis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Meropenem</keyword>
	<keyword>extend infusion</keyword>
	<keyword>prolonged infusion</keyword>
	<keyword>Time MIC</keyword>
</DOC>